CBR | Jotup

BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR

Retrieved on:

Tuesday, April 9, 2024

HER2, ILD, CPI, Survival, Progression-free survival, Central nervous system, Patient, CNS, History, Death, Eribulin, Spacecraft, MD, CBR, TPC, EMBRACE, Life, BCT, AACR, TSX, Therapy, Breast cancer, Safety, Poster, CMO, PFS, ADC, PD-1, Pharmaceutical industry

“ADCs are the latest treatments for very difficult-to-treat advanced metastatic breast cancer.

Key Points:

“ADCs are the latest treatments for very difficult-to-treat advanced metastatic breast cancer.
To our knowledge, there are no effective treatment options in this patient population for whom the progression-free survival prognosis is only a few weeks.
BriaCell will be monitoring ADC resistant patients in its ongoing pivotal Phase 3 study of Bria-IMT™ and CPI in advanced metastatic breast cancer.
Eribulin monotherapy versus treatment of physician’s choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomized study.

STIFEL TO ACQUIRE FINANCE 500 and CB RESOURCE

Retrieved on:

Thursday, March 14, 2024

ERM, Risk management, FDIC, Strategic planning, Eaton Partners, CBR, Broker-dealer, SF, Keefe, Bruyette & Woods, Security (finance)

ST. LOUIS, March 14, 2024 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced it has signed a definitive agreement to acquire Finance 500, Inc. (“Finance 500”) and CB Resource, Inc. (“CBR”).

Key Points:

ST. LOUIS, March 14, 2024 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced it has signed a definitive agreement to acquire Finance 500, Inc. (“Finance 500”) and CB Resource, Inc. (“CBR”).
Houlihan Lokey acted as exclusive financial advisor and Calfee, Halter & Griswold LLP acted as legal advisor to Finance 500 and CB Resource.
Stifel Bank and Stifel Bank & Trust offer a full range of consumer and commercial lending solutions.
Finance 500, Inc. (“Finance 500”) is a brokerage and investment services provider focused on underwriting FDIC-insured Certificates of Deposits and fixed income securities trading.

Global Cord Blood & Tissue Banking Industry Market Size, Segmentation & Forecast Report 2024 - ResearchAndMarkets.com

Retrieved on:

Friday, March 15, 2024

The "Global Cord Blood & Tissue Banking Industry Report - Market Size, Segmentation, & Forecasts, 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "Global Cord Blood & Tissue Banking Industry Report - Market Size, Segmentation, & Forecasts, 2024" report has been added to ResearchAndMarkets.com's offering.
There are now over 800,000 cord blood units stored in public cord blood banks and more than 6.75 million cord blood and tissue units stored within private banks worldwide.
Today, nearly all U.S. cord blood banks and approximately one-third of global cord blood banks offer cord tissue storage.
The report presents findings on the following topics:
Rate per cord blood unit in the U.S. and Europe
Number of clinical trials, number of published scientific papers, and amount of NIH funding for cord blood research
Number and types of patents for cord blood, cord tissue, and placental products
The report presents a comprehensive analysis of the global cord blood and tissue banking market.

73% CNS ORR! FDA Granted ODD to Utidelone Injectable (UTD1) from Biostar Pharma for the Treatment of Breast Cancer Brain Metastasis

Retrieved on:

Friday, March 29, 2024

As of now, there is only one drug approved for the treatment of BCBM globally, suggesting huge unmet medical needs [1].

Key Points:

As of now, there is only one drug approved for the treatment of BCBM globally, suggesting huge unmet medical needs [1].
Utidelone has the ability to cross BBB due to its unique physicochemical characteristic and insusceptibility to P-glycoprotein-mediated efflux.
The FDA granted ODD to utidelone injectable for the treatment of BCBM based on these promising data.
Considering utidelone's excellent BBB-crossing capability and its therapeutic potential for brain tumors, Biostar Pharma also plans to advance the clinical studies of utidelone injectable for the treatments of other brain tumors such as lung cancer brain metastasis and glioma this year.

Canada and FCM Invest $655,000 to Support Energy and Cost Saving Efforts in Communities Across Ontario

Retrieved on:

Monday, March 25, 2024

Community, Government, Climate change, Federation, Partnership, GHG, City, Natural Resources, CBR, GMF, FCM, Renewable energy

This is why the Government of Canada and the Federation of Canadian Municipalities (FCM) are continuing to invest in projects to help communities from coast-to-coast-to-coast retrofit their buildings and reduce their greenhouse gas (GHG) emissions.

Key Points:

This is why the Government of Canada and the Federation of Canadian Municipalities (FCM) are continuing to invest in projects to help communities from coast-to-coast-to-coast retrofit their buildings and reduce their greenhouse gas (GHG) emissions.
The Community Building Retrofit initiative is part of a $950-million federal investment in FCM's Green Municipal Fund (GMF) and is designed to scale up energy efficiency and lower emissions across Canada.
GMF, administered by the FCM, is funded through an endowment by the Government of Canada and helps local governments switch to sustainable practices faster.
That's why we can only welcome, with support from the federal government, GMF's delivery of the Community Buildings Retrofit initiative to enable communities across Canada, including Ontario today, to lower their emissions and improve energy performance.

OneDigital Welcomes Creative Business Resources in Phoenix

Retrieved on:

Tuesday, March 19, 2024

HR, Risk management, Growth, Partnership, Luigi, Acquisition, CBR, Insurance, PEO, Retirement

ATLANTA, March 19, 2024 /PRNewswire/ -- OneDigital, the nation's leading insurance brokerage, financial services and HR consulting firm, has acquired Creative Business Resources (CBR), an HR outsourcing leader in Phoenix, Arizona. This acquisition underscores OneDigital's commitment to converging benefits, HR, retirement, payroll and other essential business functions through its PEO platforms for small and midsized businesses.

Key Points:

ATLANTA, March 19, 2024 /PRNewswire/ -- OneDigital , the nation's leading insurance brokerage, financial services and HR consulting firm, has acquired Creative Business Resources (CBR), an HR outsourcing leader in Phoenix, Arizona.
With 30+ years of experience, Creative Business Resources is a leading provider of customized outsourced human resources, employee benefits, retirement plans, risk management and payroll services to small-to-medium-sized businesses throughout the Southwest.
Together with the entire Creative Business Resources team, OneDigital's fast-growing PEO solution will continue to serve SMBs with unmatched expertise and innovation.
In addition, over 40 CBR employees in Phoenix and Idaho Falls have joined the OneDigital team.

Arvinas Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Retrieved on:

Tuesday, February 27, 2024

NEW HAVEN, Conn., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a corporate update.

Key Points:

Median PFS of 11.1 and 11.0 months in patients with ESR1 wild-type and ESR1 mutant tumors, respectively.
Announced the appointment of Randy Teel, Ph.D., Arvinas’ current senior vice president of corporate and business development, to the role of interim chief financial officer and treasurer.
The Arvinas Board of Directors has launched a formal search process to identify Mr. Cassidy’s permanent replacement.
Revenues: Revenue was $78.5 million and $(43.1) million for the year and quarter ended December 31, 2023 as compared with $131.4 million and $38.0 million for the year and quarter ended December 31, 2022.

Huawei Launches Industry's First fgOTN-Compliant Optical Transmission Product, Creating Intelligent Foundation for Electric Power and Transportation Sectors

Retrieved on:

Wednesday, February 28, 2024

CBR, TDM, Transport, MWC, Communication, SDH, OTN, NCE

This innovation establishes a robust and reliable communication network for the energy and transportation sectors.

Key Points:

This innovation establishes a robust and reliable communication network for the energy and transportation sectors.
The significance of secure and reliable communication networks cannot be overstated in sectors vital to national economies and public welfare, such as energy and transportation.
Huawei's fgOTN-compliant optical transmission products feature:
High security and reliability: TDM-based hard pipes ensure 100% physical isolation between services.
Flexible client-side bandwidth access ranging from 2 Mbit/s to 100 Gbit/s, coupled with hitless bandwidth adjustment, addresses the evolving requirements of smart terminals.

Morphy Auctions Announces New European Division with Headquarters in Switzerland

Retrieved on:

Friday, February 9, 2024

Firearm, CBR, Weapon, Multimedia, Documentation, WWI, Jewellery, Auction

DENVER, Pa., Feb. 9, 2024 /PRNewswire/ -- Morphy Auctions officially became a multinational company today as founder and president Dan Morphy announced the launch of a European division based in Zwingen, Switzerland.

Key Points:

Munitionsdepot.ch will expedite consignment of European firearms & militaria collections, antique toys, fine & decorative art, jewelry and more to US auctions
DENVER, Pa., Feb. 9, 2024 /PRNewswire/ -- Morphy Auctions officially became a multinational company today as founder and president Dan Morphy announced the launch of a European division based in Zwingen, Switzerland.
"We've had a strong involvement with European collectors for many years, especially those who collect antique firearms and militaria," Dan Morphy said.
Christoph Borer remarked: "Being part of such a great alliance with a company as renowned as Morphy Auctions is an honor.
Dan Morphy noted: "Some firearms, like WWI and WWII European arms, sell for 2-3 times as much here as they do overseas.

Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing

Retrieved on:

Friday, February 9, 2024

DSM-IV codes, CBR, The Cooper Companies, Immunodeficiency, Health, Hearing loss, Genetic testing, EL, Cancer, Diet, Fertility, Epilepsy, Portrait, Genetics, Gene, Cord blood, Vaccine

‍TRUMBULL, Conn. and EL MONTE, Calif., Feb. 9, 2024 /PRNewswire/ -- CooperSurgical®, a global leader in fertility and women's health, and Fulgent Genetics, Inc. (NASDAQ: FLGT), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that they have partnered to offer families of Cord Blood Registry® (CBR®) exclusive newborn genetic screening panels.

Key Points:

CBR Portrait includes more than twice as many genes as CBR Snapshot and may identify more rare causes of these conditions.
CBR Landscape also includes a pharmacogenetic (PGx) component, which is a type of genetic testing that can determine how a person breaks down or metabolizes certain medications.
"Part of our mission is to use our resources and testing to improve the lives of those around us.
Newborn genetic analysis serves as an illustration of this commitment, as early intervention may significantly improve health outcomes for many of these conditions."